Music Therapy for ICU Delirium
(DDM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Critically ill older adults admitted to the intensive care unit (ICU) are at a higher risk to develop delirium, which predisposes them to longer lengths of ICU and hospital stay, increased in-patient mortality, and higher risk of new acquired cognitive impairment and dementia. Music listening is a non-pharmacological intervention that holds potential to decrease ICU delirium. The investigators propose a randomized controlled trial to evaluate the efficacy of a seven-day slow-tempo music intervention on the primary outcome of delirium/coma free days among mechanically ventilated, critically ill older adults.
Who Is on the Research Team?
Linda Chlan, PhD, RN
Principal Investigator
Mayo Clinic
Babar Khan, MD, MS
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for critically ill adults over 50 in the ICU who are expected to need a ventilator for at least 48 hours and can consent through a representative. They must speak English, have phone access, and not have hearing/vision impairments, certain neurological conditions, uncontrolled psychiatric illness, or be at risk of alcohol/drug withdrawal.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a seven-day slow-tempo music intervention to evaluate its efficacy on delirium/coma free days
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of pain, cognition, depression, and anxiety
What Are the Treatments Tested in This Trial?
Interventions
- Attention Control
- Slow Tempo Music
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator